New Clinical Data Highlighting Foundation Medicine's Next-Generation Sequencing Analysis in Breast Cancer to be Presented at SABCS
12/4/2012 10:49:42 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced that new data from its collaborations with multiple academic medical center research groups will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) taking place December 4-8, 2012 in San Antonio, Texas. These presentations highlight Foundation Medicine’s targeted next-generation sequencing platform for comprehensive molecular profiling in cancer.
comments powered by